Steroids Panel

Most hormone testing checks end products. Cortisol. Testosterone. Estradiol. A number comes back, falls inside a reference range, and the conversation ends. But your adrenal glands and gonads run a chemical assembly line with multiple steps and several enzymes, and a normal final number can hide a real problem upstream or downstream of where the lab happened to look.

A steroids panel measures the precursors, intermediates, and end hormones together. It maps the production line so you can see which step is overactive, which is jammed, and which branch is feeding the wrong product. Some of the most consequential adrenal disorders only show themselves through a precursor pattern that a single hormone test cannot reveal.

What This Panel Reveals

Every steroid hormone in your body starts as cholesterol and travels down one of three branches: glucocorticoids (the cortisol family), mineralocorticoids (the salt and blood pressure family), and androgens (the testosterone family). The same enzymes work in your adrenal glands and your gonads. This panel touches all three branches and the shared backbone they grow from.

The cortisol branch

Cortisol is the body's main stress and metabolic hormone. The panel tracks it alongside 11-deoxycortisol (the immediate precursor) and cortisone (the inactive partner that tissues switch back and forth from cortisol). Together these tell you whether the gland is making enough end hormone, whether the next-to-last enzyme step is blocked, and whether your peripheral tissues are converting cortisol correctly.

The mineralocorticoid branch

A separate adrenal branch makes the hormones that control sodium, potassium, and blood pressure. The panel measures deoxycorticosterone (often shortened to DOC), corticosterone, and 18-hydroxycorticosterone, the three intermediates that build toward aldosterone. When certain enzymes are deficient, DOC accumulates and acts as a powerful mineralocorticoid on its own, driving high blood pressure and low potassium. Without measuring these precursors, that picture is invisible.

The androgen branch

DHEA (dehydroepiandrosterone) and androstenedione are the upstream androgens that feed into testosterone. Both adrenal glands and gonads contribute. When androgens are high in the wrong context, like a woman with acne, hair growth, and irregular periods, or a man with rapid-onset symptoms, the precursor pattern points to whether the adrenal glands or the gonads are the source.

The shared backbone

Pregnenolone is the common ancestor of every steroid hormone. Progesterone is one step downstream and plays both reproductive and adrenal roles. 17-hydroxyprogesterone sits at the fork where the cortisol branch and the androgen branch diverge. Elevated 17-hydroxyprogesterone is the single most useful clue to 21-hydroxylase deficiency, the most common form of congenital adrenal hyperplasia (often shortened to CAH).

How to Read Your Results Together

The point of measuring all of these together is the pattern, not any one number. Four patterns cover the majority of clinically important findings.

For ambiguous patterns, the diagnostic standard is an adrenocorticotropic hormone (ACTH) stimulation test. Baseline steroid levels are drawn, synthetic ACTH is injected, and the same hormones are remeasured one hour later. Mild non-classic CAH often hides on a baseline draw and only appears after this stimulation.

When Results Can Be Misleading

Steroids swing with the time of day, the menstrual cycle, sleep, recent stress, and many common medications. Cortisol and the precursors driven by ACTH peak in the early morning and decline through the evening, so the entire panel should be drawn before 9 AM whenever possible. 17-hydroxyprogesterone, progesterone, and androstenedione all rise during the second half of the menstrual cycle, so cycling women should test in the early follicular phase, roughly days 2 to 5 after the period starts.

Acute illness, intense exercise, surgery, or major emotional stress can transiently raise cortisol and the precursors above it. Oral contraceptives raise sex hormone binding globulin (SHBG), which alters total testosterone interpretation. Glucocorticoid medications (prednisone, dexamethasone, even high-dose inhaled steroids) can suppress the entire panel for weeks. Spironolactone, ketoconazole, and certain antifungals interfere with adrenal enzymes directly and produce misleading results.

Tracking Over Time

Steroid panels are not one-and-done. People being treated for CAH need serial measurements to titrate glucocorticoid replacement. Too little replacement and androgens climb, driving virilization, infertility, and cardiovascular risk. Too much and bone density, growth, and metabolic health suffer. The panel as a group, not cortisol alone, is what tells you whether the dose is right.

For an adrenal nodule found on imaging, repeated steroid panels track whether the nodule has begun secreting hormone autonomously, a pattern that often emerges slowly over years. For people on testosterone or DHEA replacement, panels monitor downstream conversion and feedback suppression of the rest of the adrenal axis. Single snapshots miss trends. Serial draws make the trajectory obvious.

What to Do with Your Results

A pattern suggesting CAH, an adrenal tumor, or a mineralocorticoid disorder should be confirmed with an ACTH stimulation test, an aldosterone-to-renin ratio, and adrenal imaging. None of these are reasonable to interpret alone. Find an endocrinologist who works specifically with adrenal disorders, since many general endocrinologists see only a handful of CAH cases in a career.

If the panel returns clean and your symptoms persist, common companion tests include DHEA sulfate (a more stable adrenal androgen marker than unconjugated DHEA), ACTH, aldosterone with plasma renin activity, and SHBG with free testosterone for a fuller androgen bioavailability picture. A urinary steroid metabolite profile can capture conversion patterns this serum panel does not see.

For mild non-classic CAH discovered in adulthood, treatment ranges from observation to low-dose glucocorticoid therapy, and the decision depends on symptoms, fertility goals, and androgen burden. The point of ordering this panel proactively is to find the diagnosis early, when the choices are still wide open.